Trump Plans Steep Tariffs on Generic Drugs to Spur U. S.
Production President Donald Trump's plan to impose steep tariffs on generic drugs imported into the US starting in 2028 has sent shockwaves through the pharmaceutical industry, particularly in countries like India that rely heavily on exports of cheaper medicines.
The US is a major market for generic drugs, with India being one of the primary beneficiaries due to its large pool of skilled chemists and relatively low labor costs.